News Karnataka
Tuesday, December 05 2023

Seqirus eyes swift introduction of influenza vaccines into S. Korea

Seqirus Ltd.
Photo Credit :

Seoul: Global leading influenza vaccine maker Seqirus Ltd. said it will swiftly bring its various products into South Korea amid the yearslong pandemic.

Seqirus, part of Australia-based biotech firm CSL Ltd., is one of the largest influenza vaccine companies in the world with pipelines in the US, Britain and Australia. The company provides influenza vaccines to over 20 countries.

Seqirus set up its local corporate body, Seqirus Korea Ltd., in 2017, Yonhap news agency reported.

“We will try our best to bring various Seqirus vaccines into the country as quickly as possible,” Seqirus Korea CEO Yoo Gee-seung said during an online press conference.

Yoo also highlighted the importance of administering an influenza vaccine at the right time to boost its effectiveness after mid-October, especially as the Covid-19 pandemic continues.

Seqirus currently provides its influenza virus vaccine, Afluria Quadrivalent, in South Korea. The product can be used on adults, as well as children aged five or older.

The company said it plans to bring in two other influenza vaccines — Fluad Quadrivalent and Flucelvax Quadrivalent — sometime soon.

Share this:
Support NewsKarnataka's quality independent journalism with a small contribution.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Editor's Pick

Find the best odds at 10Cric and IPL Betting 2023! Signup today and get up to a 100% deposit bonus.

To get the latest news on WhatsApp